Nuvectis Pharma Forms Hammer Chart Pattern Time for Bottom Fishing?
| NVCT Stock | USD 10.65 0.30 2.74% |
Slightly above 62% of Nuvectis Pharma's investor base is looking to short. The analysis of the overall investor sentiment regarding Nuvectis Pharma suggests that many traders are alarmed. Nuvectis Pharma's investing sentiment can be driven by a variety of factors including economic data, Nuvectis Pharma's earnings reports, geopolitical events, and overall market trends.
After losing some value lately, a hammer chart pattern has been formed for Nuvectis Pharma , indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Read at finance.yahoo.com
 |
Nuvectis Pharma Fundamental Analysis
We analyze Nuvectis Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nuvectis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nuvectis Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Nuvectis Pharma is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Nuvectis Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nuvectis Pharma stock to make a market-neutral strategy. Peer analysis of Nuvectis Pharma could also be used in its relative valuation, which is a method of valuing Nuvectis Pharma by comparing valuation metrics with similar companies.
Peers
Nuvectis Pharma Related Equities
| REPL | Replimune | 12.07 | ||||
| GOSS | Gossamer Bio | 8.26 | ||||
| CNTA | Centessa Pharmaceuticals | 7.67 | ||||
| OLMA | Olema Pharmaceuticals | 5.83 | ||||
| LRMR | Larimar Therapeutics | 5.64 | ||||
| IVA | Inventiva | 4.76 | ||||
| CGEM | Cullinan Oncology | 2.46 | ||||
| IKNA | Ikena Oncology | 1.80 | ||||
| HOWL | Werewolf Therapeutics | 1.79 | ||||
| NAMS | NewAmsterdam Pharma | 1.68 | ||||
| KRON | Kronos Bio | 1.49 | ||||
| GLUE | Monte Rosa | 1.22 | ||||
| OBIO | Orchestra BioMed | 1.03 | ||||
| EWTX | Edgewise Therapeutics | 0.54 | ||||
| CMPX | Compass Therapeutics | 0.48 | ||||
| CELC | Celcuity LLC | 0.37 | ||||
| CCCC | C4 Therapeutics | 3.90 | ||||
| ANEB | Anebulo Pharmaceuticals | 4.72 |
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.